A phase II study of sunitinib on a continuous dosing schedule in patients (pts) with relapsed or refractory urothelial carcinoma (UC) Meeting Abstract
| Authors: | Gallagher, D. J.; Milowsky, M. I.; Gerst, S. R.; Tickoo, S.; Ishill, N.; Regazzi, A.; Trout, A.; Bajorin, D. F. |
| Abstract Title: | A phase II study of sunitinib on a continuous dosing schedule in patients (pts) with relapsed or refractory urothelial carcinoma (UC) |
| Meeting Title: | 45th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 27 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2009 May 29-Jun 2 |
| Meeting Location: | Orlando, FL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2009-05-20 |
| Start Page: | 252s |
| Language: | English |
| ACCESSION: | WOS:000276606603472 |
| PROVIDER: | wos |
| DOI: | 10.1200/jco.2009.27.15_suppl.5072 |
| Notes: | Meeting Abstract: 5072 -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
